Amlodipine, a widely prescribed calcium channel blocker used to treat hypertension and coronary artery disease, represents one of the most traded pharmaceutical active ingredients and finished dosage forms globally. The global Amlodipine Besylate market was valued at approximately US$1.0 billion in 2025 and is projected to reach US$1.2 billion by 2032. With the market continuing to expand—some estimates project growth to US$3.01 billion by 2034—understanding the global buyer landscape is essential for pharmaceutical exporters, suppliers, and business development professionals seeking to enter or expand within this market. This comprehensive guide provides a detailed Amlodipine global buyers list, covering importers, distributors, and pharmaceutical companies across key regions, backed by verified trade…